Table 2. Recent AI technologies are used to develop and identify beta-β-lactamase inhibitors.
AI Technology |
Description |
Key outcomes |
Ref. |
Ligand Competitive Saturation (SILCS) and Machine-learning based random- Forest (RF) |
Screening 700,000 chemicals for the functional group having antimicrobial activity. |
Identified CMY-10 inhibitors having potentiality to work against MD. |
[62] |
Multichannel deep neural network (DeepBLI) |
To identify potential metallo—β-lactamaseAIM-1 inhibitors and adapt rottlerin to four different classes of β-lactamase targets, demonstrating its potential as a broad-spectrum inhibitor |
Produces results with Area Under the Receiver Operating Characteristics (AUROC) of 0.9240 and AUPRC of 0.9715, indicating the ability to discover novel β-lactamase-inhibitor interactions. |
[63] |
Machine learning algorithms |
A large dataset with more than 62,000 compounds and their β-lactamase potency values AmpC was used in QSAR (quantitative structure-activity relationship) mode after being obtained from ChEMBL. |
Microorganisms containing beta-lactamases were tested for bioactivity against plant-based flavonoids and terpenoids. |
[64] |
DeepBL
|
The whole proteome was screened using the UniProt database reviewed bacterial protein sequences. |
The discovery of β-lactamase in silico
|
[65] |
Deep Learning-Assisted Photochromic Sensor
|
For use with convolutional neural networks (CNNs), a dataset of 2520 unduplicated fluorescence intensity images were collected. |
The technique permitted quick measurement with a concentration range of 1 to 100 mg/L and distinguished six -Lactams with a prediction accuracy of 97.98% |
[66] |
Bayes decision rule combined with robust statistics and a Siamese neural network |
Detection of targeted Optical Distribution Network (ODN) |
Detected T-ODN having NDM-1 enzyme like activity responsible for β -lactam antibiotics resistance. |
[67] |
Combined Support-Vector-Machine-Based Virtual Screening and Docking Method |
For the virtual screening of IMP-1 metallo-β-lactamase inhibitors, a support vector machine (SVM) and the docking method separate compounds into positives and negatives. For in vitro tests, eight of the twenty-five chosen compounds were bought. |
Four compounds have demonstrated inhibitory potency against IMP-1 Metallo-β-lactamase inhibitors. |
[68] |
Plasmonic nanosensors and Machine Learning
|
Detect nanoparticle surface plasmon resonance (SPR) spectra |
Rapid detection of (E. faecium, S. aureus, K. pneumoniae, A. baumannii, P. aeruginosa, and Enterobacter spp.) ESKAPE pathogens. |
[69] |
ML-random forest model |
Using ML to look for and find potential candidates with the properties of β-lactamase inhibition |
A search for structurally related compounds was conducted after one molecule that showed much promise, and the results revealed that all 28 of the other returning compounds had antibacterial activity. |
[62] |
Algorithm-based Artificial Neural Network |
A feature vector is created by deriving several metrics from the basic structure. Experimentally determined beta-β-lactamase data are gathered and converted into feature vectors. |
Using jackknife testing, cross-validation, and independent testing, the predictor's overall accuracy is 99.76%, 96.07%, 94.20%, and 91.65%, respectively. |
[70] |